Correlation Between Prothena Plc and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Prothena Plc and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prothena Plc and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prothena plc and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Prothena Plc and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prothena Plc with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prothena Plc and Apellis Pharmaceuticals.
Diversification Opportunities for Prothena Plc and Apellis Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Prothena and Apellis is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Prothena plc and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Prothena Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prothena plc are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Prothena Plc i.e., Prothena Plc and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Prothena Plc and Apellis Pharmaceuticals
Given the investment horizon of 90 days Prothena plc is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Prothena Plc is 1.07 times more volatile than Apellis Pharmaceuticals. It trades about -0.21 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.17 per unit of volatility. If you would invest 2,958 in Apellis Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 442.00 from holding Apellis Pharmaceuticals or generate 14.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Prothena plc vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Prothena plc |
| Apellis Pharmaceuticals |
Prothena Plc and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prothena Plc and Apellis Pharmaceuticals
The main advantage of trading using opposite Prothena Plc and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prothena Plc position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Prothena Plc vs. Equillium | Prothena Plc vs. DiaMedica Therapeutics | Prothena Plc vs. Valneva SE ADR | Prothena Plc vs. Vivani Medical |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |